GRACE THERAPEUTICS, INC.
Ownership & governance
Executives 3Directors 5Avg age 58Avg tenure 2.9y
PK
Prashant Kohli
Chief Executive Officer
Age 54Since 2023-04-03Profile →
+7
Executives3
PK
Prashant Kohli→
Chief Executive Officer
Age 54Since 2023-04-03
RD
Robert DelAversano
Director of Finance/CFO
Age 54Since 2024-01-04
RM
Robert Macdonald
Chief Tech/Sci/R&D Officer
Age 64Since 2023-05-07
Board of directors5
Shareholders5
| Name | Stake | Shares |
|---|---|---|
| Vimal Kumar Kavuru | 11.38 % | 1,761,674 |
| S. S. Pharma LLC | 6.973 % | 1,079,018 |
| Cerity Partners LLC | 5.487 % | 849,055 |
| Rajitha Grace 2018 Irrevocable Trust | 5.051 % | 781,592 |
| Eversept Partners LP | 4.889 % | 756,600 |
Catalog · 2026-07-09
Registry officers11
| Name | Role | Since | Shares |
|---|---|---|---|
| Vimal Kumar Kavuru | Chairman | — | - |
| A. Davis | Director/Board Member | 2023-10-09 | - |
| Brian Ford | Director or executive officer | — | 25,868 |
| Donald Olds | Director or executive officer | — | 17,980 |
| Edward Neugeboren | Director/Board Member | 2023-10-09 | - |
| Edward Neugeboren | Director or executive officer | — | 37,895 |
| Jan D'Alvise | Director or executive officer | — | 1,094 |
| Michael Derby | Director or executive officer | — | 11,806 |
Registry · as of 2026-09-17
Institutional (13F)
Loading Form 13F holders…
Fund membership
Loading fund baskets…
Street consensus
Consensus noneMean target 5.86Range 3.9–7.82Analysts 2
3.9Mean 5.867.82
- Buy 2
Broker actions2
| Firm | Action | To | Target | Date |
|---|---|---|---|---|
| TD Cowen | Maintained | Buy | 8 | 2026-04-24 |
| HC Wainwright & Co. | Reiterated | Buy | 12 | 2025-02-18 |
Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.